(Q46079292)

19 December 2017

title

p53 as a specific prognostic factor in triple-negative breast cancer (English)

1 reference

19 December 2017

author name string

Byung Joo Chae

1

1 reference

19 December 2017

Ja Seong Bae

2

1 reference

19 December 2017

Ahwon Lee

3

1 reference

19 December 2017

Woo Chan Park

4

1 reference

19 December 2017

Young Jin Seo

5

1 reference

19 December 2017

Byung Joo Song

6

1 reference

19 December 2017

Jung Soo Kim

7

1 reference

19 December 2017

Sang Seol Jung

8

1 reference

19 December 2017

publication date

20 March 2009

1 reference

19 December 2017

Japanese Journal of Clinical Oncology

published in

1 reference

19 December 2017

volume

39

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

217-224

1 reference

19 December 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

p53 protein overexpression and chemosensitivity in breast cancer. Institut Gustave-Roussy Breast Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Heterogeneity of breast cancer among patients and implications for patient selection for adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP007

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYP007

1 reference

19 December 2017

PubMed ID

19304743

1 reference

19 December 2017